Cargando…
Update on the Role of FeNO in Asthma Management
Asthma is a heterogenous disorder characterized by presence of different phenotypes and endotypes. Up to 10% of the individuals suffer from severe asthma and are at increased risk of morbidity and mortality. Fractional exhaled nitric oxide (FeNO) is a cost-effective, point of care biomarker that is...
Autores principales: | Murugesan, Neveda, Saxena, Damini, Dileep, Arundhati, Adrish, Muhammad, Hanania, Nicola A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137365/ https://www.ncbi.nlm.nih.gov/pubmed/37189529 http://dx.doi.org/10.3390/diagnostics13081428 |
Ejemplares similares
-
The Role of FeNO in Predicting Asthma
por: Pijnenburg, Mariëlle W.
Publicado: (2019) -
Cost-effectiveness of fractional exhaled nitric oxide (FeNO) measurement in predicting response to omalizumab in asthma
por: Brooks, Elizabeth A, et al.
Publicado: (2019) -
The value of FeNO measurement in childhood asthma: uncertainties and perspectives
por: Ferrante, Giuliana, et al.
Publicado: (2013) -
Revisiting Asthma Obstructive Sleep Apnea Overlap: Current Knowledge and Future Needs
por: Saxena, Damini, et al.
Publicado: (2023) -
FeNO as a Marker of Airways Inflammation: The Possible Implications in Childhood Asthma Management
por: Verini, Marcello, et al.
Publicado: (2010)